儿科临床药理学
上QQ阅读APP看书,第一时间看更新

参考文献

1.Yaffe SJ,Aranda JV.Neonatal and Pediatric Pharmacology:Therapeutic Principles in Practice.4th ed.Philadelphia:Lippincott Williams&Wilkins Press,2010:104-116
2.王丽.儿科药理学与药物治疗学.北京:北京医科大学出版社,2002:144-159
3.李家泰.临床药理学.北京:人民卫生出版社,2007:497-518
4.张华年,文玲莉,张少文,等.固相萃取高效液相色谱法检测生物样品中甲氨蝶呤.药物分析杂志,2000,20:401-404
5.张华年,陈渝军,刘智胜.毛细管气相色谱法检测癫痫患儿血清中丙戊酸浓度.中国医院药学杂志,2005,25:46-48
6.高仲阳,徐彦贵.治疗药物监测技术.北京:化学工业出版社,2007:18-33
7.陈冰,蔡卫民.抗癫痫药物治疗药物监测与个体化用药进展.中国药师,2010,13:200-203
8.Patsalos PN,Berry DJ,Bourgeois BF,et al.Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring:a position paper by the subcommission on therapeutic drug monitoring ILAE Commission on Therapeutic Strategies.Epilepsio,2008,49:1239-1276
9.Striano S,Striano P,Capone D,et al.Limited place for plasma monitoring of new antiepileptic drugs in clinical practice.Med Sci Monit,2008,14:173-178
10.Hung SI,Chung WH,Jee SH,et al.Genetic susceptibility m carbamazepine-induced cutaneous adverse drug reactions.Pharmacogenet Genomics,2006,16:297-306
11.Smith J,Andes D.Therapeutic drug monitoring of antifungals:pharmacokinetic and pharmacodynamic considerations.Ther Monit,2008,30:1-6
12.Andes D,Pascual A,Marchetti O.Antifungal Therapeutic Drug Monitoring:Established and Emerging Indications.Antimicrobial Agents and Chemotherapy,2009,53:24-34
13.WalshTW,Driscoll T,Milligan PA,et al.Pharmacokinetics,Safety,and Tolerability of Voriconazole in Immunocompromised Children.Antimicrobial Agents and Chemotherapy,2010,54:4116-4123
14.Worth LJ,Blyth CC,Booth DL,et al.Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders.Internal Medicine Journal,2008,38:521-537
15.胡敏,张静华,孙鹤,等.群体药动学原理及NONMEM法数据分析药学服务与研究2002,2(2):227-230
16.王刚,刘彬,黄晓英,等.非线性混合效应模型法研究卡马西平在癫痫儿童的群体药动学.中国医院药学杂志,2007,27:1001-1004
17.Romano-Moreno S,Medina-Rojas EL,Salsa-Ortiz AL,et al.Population pharmacokinetics of carbamazepine in adults with epilepsy.Rev Invest Clin,2005,57:38-48
18.姜德春,王丽,卢炜.用NONMEN法建立中国癫痫儿童丙戊酸群体药动学/药效学结合模型.中国临床药理学与治疗学,2005,19:1279-1285